Some professions — think tenured professor or Supreme Court justice — are largely insulated from the pressure to maintain a specific look. The same cannot be said in the high-stakes arenas of finance, real estate and design, where the quest for a competitive edge has well-established self-maintenance rituals: coloring gray hairs, meticulously curated wardrobe and submitting oneself to Botox needles.
Now, that pursuit has evolved to include another new, potent class of injectable: glucagon-like peptide-1 drugs like Ozempic, Wegovy and Zepbound.
